Holen Sie sich die Stockscreener-App
14.74
4.02%
0.57
Handel nachbörslich:
14.80
0.06
+0.41%
Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
20.09%
2.589
|
3.24 | 2.614 | 1.784 | 2.292 |
| Operating Income/Loss |
20.09%
-2.589
|
-3.24 | -2.614 | -1.784 | -2.292 |
| Nonoperating Income/Loss |
36.53%
0.106
|
0.167 | 0.165 | 0.185 | 0.124 |
| Income/Loss From Continuing Operations Before Tax |
83.99%
-2.483
|
-15.51 | -2.449 | -1.599 | -2.168 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
83.99%
-2.483
|
-15.51 | -2.449 | -1.599 | -2.168 |
|
Net Income/Loss
|
83.99%
-2.483
|
-15.51 | -2.449 | -1.599 | -2.168 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
100.00%
-
|
-12.43 | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
4.91%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):